ChartMill · Nov 3, 2026
Clarivate (NYSE:CLVT) Q3 EPS Beat Offset by Revenue Miss
Clarivate Q3 non-GAAP EPS beat consensus, but revenue missed by 16.7%, sending CLVT shares lower as investors assess divestiture impact.
NYSE · CLVT
Technology · Information Technology Services
$2.37
Up+$0.03 (+1.28%)
Updated Nov 10, 2026, 3:24 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · CLVT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 9, 2026
CLVT closed at $2.37 after 21 trading sessions, up 47.20% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | $2.33 | $2.385 | $2.195 | $2.37 | 3.63M |
| Nov 6, 2026 | $2.27 | $2.405 | $2.24 | $2.34 | 4.69M |
| Nov 5, 2026 | $2.19 | $2.34 | $2.075 | $2.33 | 7.13M |
| Nov 4, 2026 | $2.05 | $2.39 | $2.05 | $2.12 | 8.01M |
| Nov 3, 2026 | $1.62 | $2.105 | $1.60 | $2.09 | 11.85M |
| Nov 2, 2026 | $1.67 | $1.75 | $1.63 | $1.66 | 4.25M |
| Oct 30, 2026 | $1.69 | $1.715 | $1.61 | $1.65 | 4.15M |
| Oct 29, 2026 | $1.80 | $1.80 | $1.62 | $1.72 | 5.94M |
| Oct 28, 2026 | $1.79 | $1.815 | $1.715 | $1.76 | 2.95M |
| Oct 27, 2026 | $1.86 | $1.86 | $1.78 | $1.82 | 2.19M |
| Oct 26, 2026 | $1.86 | $1.88 | $1.795 | $1.87 | 2.51M |
| Oct 23, 2026 | $1.87 | $1.9399 | $1.8303 | $1.87 | 3.88M |
| Oct 22, 2026 | $1.76 | $1.86 | $1.755 | $1.85 | 3.86M |
| Oct 21, 2026 | $1.77 | $1.82 | $1.72 | $1.76 | 3.6M |
| Oct 20, 2026 | $1.80 | $1.85 | $1.765 | $1.78 | 2.86M |
| Oct 19, 2026 | $1.76 | $1.81 | $1.75 | $1.76 | 3M |
| Oct 16, 2026 | $1.76 | $1.79 | $1.70 | $1.77 | 3.69M |
| Oct 15, 2026 | $1.65 | $1.77 | $1.62 | $1.74 | 5.62M |
| Oct 14, 2026 | $1.56 | $1.61 | $1.54 | $1.61 | 2.85M |
| Oct 13, 2026 | $1.62 | $1.635 | $1.57 | $1.60 | 3.03M |
| Oct 12, 2026 | $1.60 | $1.62 | $1.56 | $1.61 | 2.04M |
The latest Smart Investors Daily articles mentioning CLVT.
Company
Market Activity
Research & News
CLVT research
Company profile and research snapshot.
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 5, 2026 | Goldman Sachs | Neutral | — |
| Jul 30, 2026 | Barclays | Underweight | — |
| Jul 30, 2026 | Stifel | Buy | — |
| Jul 30, 2026 | Goldman Sachs | Neutral | — |
| Jul 30, 2026 | Citigroup | Neutral | — |
No generated briefing is available yet.
ChartMill · Nov 3, 2026
Clarivate Q3 non-GAAP EPS beat consensus, but revenue missed by 16.7%, sending CLVT shares lower as investors assess divestiture impact.
SeekingAlpha · Nov 3, 2026
Clarivate Plc (CLVT) Q3 2026 Earnings Call November 3, 2026 8:30 AM ESTCompany ParticipantsMark Donohue - Head of Investor RelationsMatti Shem Tov - CEO...
Benzinga · Nov 3, 2026
Clarivate (NYSE:CLVT) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Benzinga · Nov 3, 2026
Clarivate (NYSE:CLVT) lowers FY2026 GAAP EPS guidance from $(0.64)-$(0.54) to $(0.65)-$(0.62) vs $(0.46) analyst estimate..
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CLVT.